6130.TWO Singbao International Co Ltd

Healthcare Pharmaceuticals Taiwan OTC Exchange
24.75 TWD
Close of Nov 6, 2026
19.80 48.30
Market cap
TWD 1.22B
P/E
-
P/B
2.29x
ROE
-0.5%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 6130.TWO undervalued?

Graham number

The Graham number of Singbao International Co Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Singbao International Co Ltd fundamental analysis

No fundamental analysis for Singbao International Co Ltd yet.

Singbao International Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Singbao International Co Ltd

Shangya Technology Co., Ltd. engages in the generic drugs and solar power generation businesses in Taiwan and Asia. The company wholesales Chinese and Western medicines, medical equipment, and beauty and hair care products; and onrito, lixin fumitation, lufuxing film-coated, amperex film coating, leverb-coated, triton film-coated, special core stabilized, tanlipo film-coated, inhibitory film-coated, yoyo flat mouth dissolved, and binlishu film-coated tablet, as well as pain …

Full company profile